Protagenic Therapeutics, Inc.\new Prepaid Expense and Other Assets, Current
Protagenic Therapeutics, Inc.\new (PTIX) had Prepaid Expense and Other Assets, Current of $56.94 thousand as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2023-03-31
- 2022-12-31: Prepaid Expense and Other Assets, Current $56.94K.
- 2021-12-31: Prepaid Expense and Other Assets, Current $688.67K.
- 2020-12-31: Prepaid Expense and Other Assets, Current $208.16K.
- 2011-09-30: Prepaid Expense and Other Assets, Current $900.00K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2022-12-31 | $56.94K 10-K · filed 2023-03-31 |
| 2021-12-31 | $688.67K 10-K · filed 2023-03-31 |
| 2020-12-31 | $208.16K 10-K · filed 2022-04-07 |
| 2011-09-30 | $900.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.01M 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $565.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |